"In this image, we see a pathway diagram showing various genes and the regulatory relationships between them. I will list the relationships as per the instructions, using \"gene1\" to represent the starter and \"gene2\" as the receptor.\n\nActivation Relationships:\n1. HER activates EGFR.\n2. EGFR activates Ras.\n3. Ras activates Raf.\n4. Raf activates MEK.\n5. MEK activates ERK.\n6. ERK activates (Nucleus for) Proliferation, Survival, Angiogenesis.\n7. EGFR activates PI3K.\n8. PI3K activates Akt.\n9. Akt activates mTOR.\n\nInhibition Relationships:\n1. Cetuximab inhibits EGFR.\n2. PF-00299804 / BIBW2992 inhibits EGFR.\n3. Erlotinib / Gefitinib inhibits EGFR.\n4. Salirasib inhibits Ras.\n5. LY294002 inhibits PI3K.\n6. BEZ235 inhibits PI3K and mTOR.\n7. Rapamycin / RAD001 / CCI-779 inhibits mTOR.\n\nPlease note that the solid lines represent direct relationships, while the dashed lines represent indirect relationships. The T-bars represent inhibitory effects, while the arrows represent activation effects."